Warner Pharmaceuticals announced that the controlling shareholder, Hunan Warner Pharmaceuticals Investment Partnership, reduced its holdings of the company by 1.38 million shares through a bulk transaction on September 17, 2026. The total shareholding ratio of Warner Pharmaceuticals and Hunan Warner Zhizhen Industrial Investment Partnership, fell from 39.09% to 38.06%, and the change in equity hit an integer factor of 1%. This change in equity means that Li Mengchun changed shares from indirect holdings to direct holdings. It does not constitute a reduction in holdings in the market. The plan to reduce holdings has not yet been implemented.

Warner Pharmaceuticals announced that the controlling shareholder, Hunan Warner Pharmaceuticals Investment Partnership, reduced its holdings of the company by 1.38 million shares through a bulk transaction on September 17, 2026. The total shareholding ratio of Warner Pharmaceuticals and Hunan Warner Zhizhen Industrial Investment Partnership, fell from 39.09% to 38.06%, and the change in equity hit an integer factor of 1%. This change in equity means that Li Mengchun changed shares from indirect holdings to direct holdings. It does not constitute a reduction in holdings in the market. The plan to reduce holdings has not yet been implemented.